snATAC-seq data was first processed using pycisTopic 24 to identify differentially accessible regions (DARs) and sets of co-accessible regions (termed topics)
It provides potentially more effective method to fulfill the vitamin deficiencies in body against oral dosage form which needs to be passed through digestive system
former Fed Chair Paul Volcker
XDB1060000 for L.P.), National Natural Science Foundation of China (32071219, 92253301, 21822705 for L.P., 81830068 for Y.-F.Y., 82472285 for D.W., and 32071297 for J.L.), the National Basic Research Program of China (2022YFC2303102 for L.P.), the CAS Youth Interdisciplinary Team (JCTD-2022-10 for L.P.), the STI2030-Major Projects (2022ZD0207400 for Y.Z.), Shanghai Key Laboratory of Aging Studies (19DZ2260400 for Y.Z.), the Basic Research Pioneer Project by the Science and Technology Commission of Shanghai Municipality (STCSM for Y.Z.), and the Foundation of Key Laboratory of Veterinary Biotechnology, Shanghai, P.R

This infographic provides a structured, high-yield overview aligned with clinical and academic frameworks, covering: Core pharmacology and mechanism of action Key pharmacological effects on glucose homeostasis and appetite regulation Evidence-based therapeutic indications (Type 2 Diabetes & Obesity) Safety profile including side effects, toxicity risks, and contraindications Pharmacokinetics: metabolism, half-life, and excretion pathways Drug-drug interaction considerations for clinical optimization Overview of globally recognized brands such as semaglutide, liraglutide, dulaglutide, and tirzepatide formulations From enhancing insulin secretion to delaying gastric emptying, GLP-1 analogs are redefining patient-centric outcomes with a strong efficacy-safety balance